These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


132 related items for PubMed ID: 17904833

  • 21. Prostaglandin-mediated signaling in schizophrenia.
    Smesny S.
    Int Rev Neurobiol; 2004; 59():255-71. PubMed ID: 15006491
    [No Abstract] [Full Text] [Related]

  • 22. Antisaccade deficit is present in young first-episode patients with schizophrenia but not in their healthy young siblings.
    de Wilde OM, Bour L, Dingemans P, Boerée T, Linszen D.
    Psychol Med; 2008 Jun; 38(6):871-5. PubMed ID: 17949519
    [Abstract] [Full Text] [Related]

  • 23. Increased NoGo-anteriorisation in first-episode schizophrenia patients during Continuous Performance Test.
    Kleinlogel H, Strik W, Begré S.
    Clin Neurophysiol; 2007 Dec; 118(12):2683-91. PubMed ID: 17910935
    [Abstract] [Full Text] [Related]

  • 24. P300 deficits are present in young first-episode patients with schizophrenia and not in their healthy young siblings.
    de Wilde OM, Bour LJ, Dingemans PM, Koelman JH, Boerée T, Linszen DH.
    Clin Neurophysiol; 2008 Dec; 119(12):2721-6. PubMed ID: 18986832
    [Abstract] [Full Text] [Related]

  • 25. Niacin sensitivity and the arachidonic acid pathway in schizophrenia.
    Messamore E, Hoffman WF, Yao JK.
    Schizophr Res; 2010 Sep; 122(1-3):248-56. PubMed ID: 20417059
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Flushing profile of extended-release niacin/laropiprant versus gradually titrated niacin extended-release in patients with dyslipidemia with and without ischemic cardiovascular disease.
    Maccubbin D, Koren MJ, Davidson M, Gavish D, Pasternak RC, Macdonell G, Mallick M, Sisk CM, Paolini JF, Mitchel Y.
    Am J Cardiol; 2009 Jul 01; 104(1):74-81. PubMed ID: 19576324
    [Abstract] [Full Text] [Related]

  • 28. Schizophrenia: a biochemical disorder?
    Horrobin DF.
    Biomedicine; 1980 May 01; 32(2):54-5. PubMed ID: 7388116
    [Abstract] [Full Text] [Related]

  • 29. Potential use of the topical niacin skin test in early psychosis -- a combined approach using optical reflection spectroscopy and a descriptive rating scale.
    Smesny S, Berger G, Rosburg T, Riemann S, Riehemann S, McGorry P, Sauer H.
    J Psychiatr Res; 2003 May 01; 37(3):237-47. PubMed ID: 12650743
    [Abstract] [Full Text] [Related]

  • 30. Decreased T cellular immune response in schizophrenic patients.
    Riedel M, Spellmann I, Schwarz MJ, Strassnig M, Sikorski C, Möller HJ, Müller N.
    J Psychiatr Res; 2007 May 01; 41(1-2):3-7. PubMed ID: 16434055
    [Abstract] [Full Text] [Related]

  • 31. Impaired flush response to niacin skin patch among schizophrenia patients and their nonpsychotic relatives: the effect of genetic loading.
    Chang SS, Liu CM, Lin SH, Hwu HG, Hwang TJ, Liu SK, Hsieh MH, Guo SC, Chen WJ.
    Schizophr Bull; 2009 Jan 01; 35(1):213-21. PubMed ID: 18203758
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Effects of aspirin when added to the prostaglandin D2 receptor antagonist laropiprant on niacin-induced flushing symptoms.
    Dishy V, Liu F, Ebel DL, Atiee GJ, Royalty J, Reilley S, Paolini JF, Wagner JA, Lai E.
    J Clin Pharmacol; 2009 Apr 01; 49(4):416-22. PubMed ID: 19246721
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Attenuated and delayed niacin skin flushing in schizophrenia and affective disorders: A potential clinical auxiliary diagnostic marker.
    Wang DD, Hu XW, Jiang J, Sun LY, Qing Y, Yang XH, Gao Y, Cui GP, Li MH, Wang PK, Zhang J, Zhuang Y, Li ZZ, Li J, Guan LL, Zhang TH, Wang JJ, Ji F, Wan CL.
    Schizophr Res; 2021 Apr 01; 230():53-60. PubMed ID: 33677199
    [Abstract] [Full Text] [Related]

  • 39. Role of prostaglandin D2 and the autonomic nervous system in niacin-induced flushing.
    Parson HK, Harati H, Cooper D, Vinik AI.
    J Diabetes; 2013 Mar 01; 5(1):59-67. PubMed ID: 22727040
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.